Type 2 diabetes (T2D) has been proven to raise the risk of cardiovascular complications, but a diagnosis doesn’t necessarily mean an inevitable slide toward those outcomes, according to the authors of a new study in the Journal of the American College of Cardiology.

Diabetes triples the risk of death from ischemic heart disease or stroke in women and doubles the risk in men with no previous vascular disease, according to new research published in The Lancet Diabetes & Endocrinology.

Red blood cell (RBC) transfusions during surgery are associated with double the risk of venous thromboembolism (VTE) over the ensuing 30 days, researchers reported in JAMA Surgery.

Baylor St. Luke’s Medical Center in Houston reopened its heart transplant program June 15 after a two-week suspension in which the hospital conducted an internal review of two recent patient deaths.

Patients who experience an adverse change in employment—such as being laid off—after a heart attack reportedly have a lower quality of life, increased depression and more difficulty affording medications, according to a study published in Circulation on June 12.

An early discharge strategy with rivaroxaban reduces hospital lengths of stay and healthcare costs for patients with low-risk pulmonary embolism (LRPE)—without compromising their safety—suggests a study published in Academic Emergency Medicine.

The 200 and 250 millimeter lengths of Medtronic’s IN.PACT Admiral drug-coated balloon gained FDA approval to treat long superficial artery (SFA) lesions in patients with peripheral artery disease (PAD), the company announced June 15.

New research suggests flavorings in electronic cigarettes, or e-cigarettes—including mint, vanilla, cinnamon and strawberry—can adversely affect endothelial cells, according to a study published June 14 in Arteriosclerosis, Thrombosis, and Vascular Biology.